Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthrax”

81 trials

Showing 20 of 81 results

Post-approval studies (Phase 4)WithdrawnNCT02969746
What this trial is testing

Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral Anticoagulants

Who this might be right for
Anticoagulants; Circulating, Hemorrhagic Disorder
University Hospital, Angers
Large-scale testing (Phase 3)Study completedNCT02016963
What this trial is testing

An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

Who this might be right for
Therapeutic Treatment of Inhalation Anthrax
Human Genome Sciences Inc. 20
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Not Yet RecruitingNCT06858436
What this trial is testing

SGLT2 Inhibitor Utilization Re-perfusion Therapy

Who this might be right for
Acute Ischemic Stroke From Large Vessel Occlusion
Taichung Veterans General Hospital 150
Early research (Phase 1)Study completedNCT03352466
What this trial is testing

NasoShield Study of Safety and Immunogenicity

Who this might be right for
Healthy Volunteers
Altimmune, Inc. 145
Early research (Phase 1)Study completedNCT00103467
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

Who this might be right for
Prevention of Anthrax Infection
VaxGen 100
Not applicableStudy completedNCT01690559
What this trial is testing

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Who this might be right for
Infection
Bayer 704
Early research (Phase 1)Study completedNCT01929226
What this trial is testing

Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 280
Early research (Phase 1)Study completedNCT01932242
What this trial is testing

Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers

Who this might be right for
Inhalational Anthrax
Elusys Therapeutics 70
Early research (Phase 1)Study completedNCT00412477
What this trial is testing

A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 18
Large-scale testing (Phase 3)Study completedNCT01491607
What this trial is testing

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Anthrax
Emergent BioSolutions 200
Early research (Phase 1)Study completedNCT02239172
What this trial is testing

PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine

Who this might be right for
Anthrax
Fraunhofer, Center for Molecular Biotechnology 30
Testing effectiveness (Phase 2)Study completedNCT01794182
What this trial is testing

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals

Who this might be right for
Ischemic StrokeMalignant Edema
Remedy Pharmaceuticals, Inc. 86
Post-approval studies (Phase 4)Not Yet RecruitingNCT02177721
What this trial is testing

Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario

Who this might be right for
Infections, Bacterial
Emergent BioSolutions 100
Testing effectiveness (Phase 2)Study completedNCT00845650
What this trial is testing

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

Who this might be right for
Anthrax
Emergent BioSolutions 129
Not applicableUnknownNCT06365073
What this trial is testing

A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax

Who this might be right for
Anthrax
Qin Ning 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05997264
What this trial is testing

Anthrax AV7909 Boost Evaluation Study

Who this might be right for
Anthrax
Biomedical Advanced Research and Development Authority 220
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableNot Yet RecruitingNCT03569514
What this trial is testing

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

Who this might be right for
Anthrax
Emergent BioSolutions 10
Testing effectiveness (Phase 2)WithdrawnNCT04928950
What this trial is testing

Charcoal in Lung Cancer Patients Undergoing TEMLA

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation